Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-08-18

Clinical Trial Update: Safety and Effectiveness of Flaxseed for Reducing High Cholesterol [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 clinical trial evaluated the safety and effectiveness of flaxseed for reducing high cholesterol in individuals with hypercholesterol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flaxseed (Linum usitatissimum seed)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Hypercholesterolemia | Phase 2, Phase 3 | Status: COMPLETED